Anti-PF4 antibody negative cerebral venous sinus thrombosis without thrombocytopenia following immunization with COVID-19 vaccine in an elderly non-comorbid Indian male, managed with conventional heparin-warfarin based anticoagulation

Diabetes Metab Syndr. 2021 Jul-Aug;15(4):102184. doi: 10.1016/j.dsx.2021.06.021. Epub 2021 Jun 24.
No abstract available

Keywords: COVID-19/Vaccination; CVT; ChAdOx1 nCOV-19 (Oxford-AstraZeneca)/COVISHIELD; Thrombocytopenia; VITT.

Publication types

  • Case Reports

MeSH terms

  • Anticoagulants / therapeutic use
  • Autoantibodies / immunology
  • COVID-19 / prevention & control*
  • COVID-19 Vaccines / adverse effects*
  • Cerebral Angiography
  • ChAdOx1 nCoV-19
  • Heparin / therapeutic use
  • Humans
  • India
  • Lateral Sinus Thrombosis / chemically induced
  • Lateral Sinus Thrombosis / diagnostic imaging
  • Lateral Sinus Thrombosis / drug therapy
  • Magnetic Resonance Angiography
  • Male
  • Middle Aged
  • Phlebography
  • Platelet Factor 4 / immunology
  • SARS-CoV-2
  • Sagittal Sinus Thrombosis / chemically induced
  • Sagittal Sinus Thrombosis / diagnostic imaging
  • Sagittal Sinus Thrombosis / drug therapy
  • Sinus Thrombosis, Intracranial / chemically induced*
  • Sinus Thrombosis, Intracranial / diagnostic imaging
  • Sinus Thrombosis, Intracranial / drug therapy
  • Thrombocytopenia
  • Warfarin / therapeutic use

Substances

  • Anticoagulants
  • Autoantibodies
  • COVID-19 Vaccines
  • PF4 protein, human
  • Platelet Factor 4
  • Warfarin
  • Heparin
  • ChAdOx1 nCoV-19